Gordon Research Conferences
Meeting Details

Antibody Biology and Engineering (GRS)
Gordon Research Seminar

Manipulating the Immune System with Natural and Synthetic Antibodies


March 24-25, 2018


Renaissance Tuscany Il Ciocco
Lucca (Barga), Italy Site Information


Jonathan T. Sockolosky & Jean-Philippe Burckert

Application Deadline

Applications for this meeting must be submitted by February 24, 2018. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.

GRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above, any applicants who wish to be considered for an oral presentation should submit their application by December 24, 2017. Please refer to the application instructions in the Meeting Description section below for more details (if available).

Meeting Description


The Gordon Research Seminar on Antibody Biology and Engineering is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

The focus of the 2018 "Antibody Biology and Engineering" GRS is on biological processes that promote or limit antibody responses against tumors, foreign pathogens, and self-antigens, and how this knowledge is utilized to engineer next-generation antibodies to treat human diseases. The seminar will combine many aspects of antibody research with a particular focus on understanding and manipulating immune responses using natural and synthetic antibodies. Topics will span basic antibody biology, structure, function and diversity, through engineering approaches and clinical applications of antibodies as therapeutics. By intersecting industrial and academic investigators, this GRS will provide a platform to initiate fruitful collaborations aiming to design the next generation of antibody therapeutics to treat inflammatory and neurological diseases, infection, and cancer.

Application Instructions

The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.

The Chairs will select speakers from abstracts submitted by December 24, 2017. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Deadline section above.

Program Format

Saturday Sunday
  • Introductory Comments: 3:00 pm - 3:15 pm
  • Introductory Science Session: 3:15 pm - 4:00 pm
  • Poster Session I: 4:00 pm - 5:30 pm
  • Evening Science Session: 5:30 pm - 7:30 pm
  • Dinner: 8:00 pm
  • Breakfast: 7:30 am - 8:30 am
  • Morning Science Session: 9:00 am - 11:00 am
  • Poster Session II: 11:00 am - 12:30 pm
  • Lunch: 12:30 pm - 1:30 pm
  • Concluding Science Session: 1:30 pm - 2:30 pm
  • Evaluation Period: 2:30 pm - 3:00 pm
  • Program for related GRC begins: 6:00 pm

Related Meeting

This GRS will be held in conjunction with the "Antibody Biology and Engineering" Gordon Research Conference (GRC). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information.


Stanford Cancer Institute
Distributed Bio Inc.
EMC Microcollections GmbH
Taylor & Francis - mAbs

Preliminary Program Outline

An outline of the program components for this GRS is displayed below. The Conference Chair is currently developing their detailed program schedule, which will include the speakers they select from submitted abstracts, in addition to any additional components outlined below. The detailed program will be available by January 24, 2018. Please check back for updates.

Keynote Speaker

  • Jacob Glanville (Distributed Bio Inc., USA)
    "Computational Epitope Focusing Enables Universal Vaccine Design, or How I Became a Guatemalan Pig Farmer"


  • To Be Selected from Submitted Abstracts

Discussion Leaders

  • Jeanette Leusen (University Medical Center Utrecht, The Netherlands)

Additional Discussion Leaders May Be Selected from Submitted Abstracts

Mentorship Component

"Building a Successful Academic Lab or Biotech Start-Up"

  • James Ernst (Genentech, USA)
  • Sally Ward (Texas A&M Health Science Center, USA)
  • Mark Hogarth (Burnet Institute, Australia)
  • Sai Reddy (ETH Zurich, Switzerland)
  • Jacob Glanville (Distributed Bio Inc., USA)
© 2017 Gordon Research Conferences Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter